BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Regimbeau JM, Abdalla EK, Vauthey JN, Lauwers GY, Durand F, Nagorney DM, Ikai I, Yamaoka Y, Belghiti J. Risk factors for early death due to recurrence after liver resection for hepatocellular carcinoma: results of a multicenter study. J Surg Oncol. 2004;85:36-41. [PMID: 14696085 DOI: 10.1002/jso.10284] [Cited by in Crossref: 99] [Cited by in F6Publishing: 95] [Article Influence: 5.5] [Reference Citation Analysis]
Number Citing Articles
1 Gomez D, Farid S, Malik HZ, Young AL, Toogood GJ, Lodge JPA, Prasad KR. Preoperative Neutrophil-to-Lymphocyte Ratio as a Prognostic Predictor after Curative Resection for Hepatocellular Carcinoma. World J Surg 2008;32:1757-62. [DOI: 10.1007/s00268-008-9552-6] [Cited by in Crossref: 278] [Cited by in F6Publishing: 283] [Article Influence: 19.9] [Reference Citation Analysis]
2 Moriguchi M, Takayama T, Higaki T, Kimura Y, Yamazaki S, Nakayama H, Ohkubo T, Aramaki O. Early cancer-related death after resection of hepatocellular carcinoma. Surgery. 2012;151:232-237. [PMID: 21176935 DOI: 10.1016/j.surg.2010.10.017] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
3 Woodall CE, Scoggins CR, Loehle J, Ravindra KV, McMasters KM, Martin RC. Hepatic imaging characteristics predict overall survival in hepatocellular carcinoma. Ann Surg Oncol 2007;14:2824-30. [PMID: 17690939 DOI: 10.1245/s10434-007-9525-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
4 Zhang X, Li C, Wen T, Peng W, Yan L, Yang J. Outcomes of Salvage Liver Transplantation and Re-resection/Radiofrequency Ablation for Intrahepatic Recurrent Hepatocellular Carcinoma: A New Surgical Strategy Based on Recurrence Pattern. Dig Dis Sci 2018;63:502-14. [PMID: 29238896 DOI: 10.1007/s10620-017-4861-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
5 Muscari F, Guinard JP, Kamar N, Peron JM, Otal P, Suc B. Impact of preoperative α-fetoprotein level on disease-free survival after liver transplantation for hepatocellular carcinoma. World J Surg. 2012;36:1824-1831. [PMID: 22532309 DOI: 10.1007/s00268-012-1587-z] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
6 Ahn SG, Kim SH, Jeon TJ, Cho HJ, Choi SB, Yun MJ, Lee JD, Kim KS. The role of preoperative [18F]fluorodeoxyglucose positron emission tomography in predicting early recurrence after curative resection of hepatocellular carcinomas. J Gastrointest Surg. 2011;15:2044-2052. [PMID: 21904962 DOI: 10.1007/s11605-011-1660-1] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 2.3] [Reference Citation Analysis]
7 Chua TC, Morris DL. Exploring the role of resection of extrahepatic metastases from hepatocellular carcinoma. Surg Oncol. 2012;21:95-101. [PMID: 21397495 DOI: 10.1016/j.suronc.2011.01.005] [Cited by in Crossref: 44] [Cited by in F6Publishing: 39] [Article Influence: 4.0] [Reference Citation Analysis]
8 Motosugi U, Bannas P, Sano K, Reeder SB. Hepatobiliary MR contrast agents in hypovascular hepatocellular carcinoma. J Magn Reson Imaging 2015;41:251-65. [PMID: 25104398 DOI: 10.1002/jmri.24712] [Cited by in Crossref: 34] [Cited by in F6Publishing: 24] [Article Influence: 4.3] [Reference Citation Analysis]
9 Wang Z, Hu J, Qiu SJ, Huang XW, Dai Z, Tan CJ, Zhou J, Fan J. An investigation of the effect of sorafenib on tumour growth and recurrence after liver cancer resection in nude mice independent of phosphorylated extracellular signal-regulated kinase levels. Expert Opin Investig Drugs. 2011;20:1039-1045. [PMID: 21671804 DOI: 10.1517/13543784.2011.588598] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
10 Muhi A, Ichikawa T, Motosugi U, Sano K, Fatima Z, Matsuda M, Fujii H, Enomoto N, Araki T. Diffusion-weighted imaging of hepatocellular carcinoma for predicting early recurrence and survival after hepatectomy. Hepatol Int 2013;7:662-8. [PMID: 26201799 DOI: 10.1007/s12072-012-9383-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
11 Wu MT, Tzang BS, Chang YY, Chiu CH, Kang WY, Huang CH, Chen YC. Effects of Antrodia camphorata on alcohol clearance and antifibrosis in livers of rats continuously fed alcohol. J Agric Food Chem 2011;59:4248-54. [PMID: 21401100 DOI: 10.1021/jf104561h] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 2.5] [Reference Citation Analysis]
12 Mathai AM, Kapadia MJ, Alexander J, Kernochan LE, Swanson PE, Yeh MM. Role of Foxp3-positive tumor-infiltrating lymphocytes in the histologic features and clinical outcomes of hepatocellular carcinoma. Am J Surg Pathol. 2012;36:980-986. [PMID: 22446942 DOI: 10.1097/pas.0b013e31824e9b7c] [Cited by in Crossref: 37] [Cited by in F6Publishing: 27] [Article Influence: 3.7] [Reference Citation Analysis]
13 Durand F, Belghiti J, Paradis V. Liver transplantation for hepatocellular carcinoma: role of biopsy. Liver Transpl. 2007;13:S17-S23. [PMID: 17969095 DOI: 10.1002/lt.21326] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 2.3] [Reference Citation Analysis]
14 Wu B, Jia F, Li X, Li L, Wang K, Han D. Comparative Study of Amide Proton Transfer Imaging and Intravoxel Incoherent Motion Imaging for Predicting Histologic Grade of Hepatocellular Carcinoma. Front Oncol 2020;10:562049. [PMID: 33194630 DOI: 10.3389/fonc.2020.562049] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
15 Pawlik TM, Gleisner AL, Anders RA, Assumpcao L, Maley W, Choti MA. Preoperative assessment of hepatocellular carcinoma tumor grade using needle biopsy: implications for transplant eligibility. Ann Surg. 2007;245:435-442. [PMID: 17435551 DOI: 10.1097/01.sla.0000250420.73854.ad] [Cited by in Crossref: 145] [Cited by in F6Publishing: 133] [Article Influence: 9.7] [Reference Citation Analysis]
16 Qian YB, Zhang JB, Wu WZ, Fang HB, Jia WD, Zhuang PY, Zhang BH, Pan Q, Xu Y, Wang L, Tang ZY, Sun HC. P48 is a predictive marker for outcome of postoperative interferon-alpha treatment in patients with hepatitis B virus infection-related hepatocellular carcinoma. Cancer 2006;107:1562-9. [PMID: 16948122 DOI: 10.1002/cncr.22206] [Cited by in Crossref: 40] [Cited by in F6Publishing: 37] [Article Influence: 2.5] [Reference Citation Analysis]
17 Yokoo H, Kondo T, Okano T, Nakanishi K, Sakamoto M, Kosuge T, Todo S, Hirohashi S. Protein expression associated with early intrahepatic recurrence of hepatocellular carcinoma after curative surgery. Cancer Sci. 2007;98:665-673. [PMID: 17391314 DOI: 10.1111/j.1349-7006.2007.00441.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.2] [Reference Citation Analysis]
18 Chun JM, Kwon HJ, Sohn J, Kim SG, Park JY, Bae HI, Yun YK, Hwang YJ. Prognostic factors after early recurrence in patients who underwent curative resection for hepatocellular carcinoma. J Surg Oncol. 2011;103:148-151. [PMID: 21259248 DOI: 10.1002/jso.21786] [Cited by in Crossref: 59] [Cited by in F6Publishing: 63] [Article Influence: 4.9] [Reference Citation Analysis]
19 Motosugi U. Hypovascular hypointense nodules on hepatocyte phase gadoxetic acid-enhanced MR images: too early or too progressed to determine hypervascularity. Radiology 2013;267:317-8. [PMID: 23525722 DOI: 10.1148/radiol.13122186] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
20 Muscari F, Foppa B, Carrere N, Kamar N, Peron J, Suc B. Resection of a Transplantable Single-Nodule Hepatocellular Carcinoma in Child-Pugh Class A Cirrhosis: Factors Affecting Survival and Recurrence. World J Surg 2011;35:1055-62. [DOI: 10.1007/s00268-011-1000-3] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
21 Huang X, Xiao Z, Zhang Y, Lin N, Xiong M, Huang X, Chen Q, Cao D. Hepatocellular Carcinoma: Retrospective Evaluation of the Correlation Between Gadobenate Dimeglumine-Enhanced Magnetic Resonance Imaging and Pathologic Grade. J Comput Assist Tomogr 2018;42:365-72. [PMID: 29369947 DOI: 10.1097/RCT.0000000000000707] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
22 Lang H, Sotiropoulos GC, Dömland M, Frühauf NR, Paul A, Hüsing J, Malagó M, Broelsch CE. Liver resection for hepatocellular carcinoma in non-cirrhotic liver without underlying viral hepatitis. Br J Surg 2005;92:198-202. [PMID: 15609381 DOI: 10.1002/bjs.4763] [Cited by in Crossref: 70] [Cited by in F6Publishing: 58] [Article Influence: 4.1] [Reference Citation Analysis]
23 Kaibori M, Ishizaki M, Saito T, Matsui K, Kwon AH, Kamiyama Y. Risk factors and outcome of early recurrence after resection of small hepatocellular carcinomas. Am J Surg. 2009;198:39-45. [PMID: 19178896 DOI: 10.1016/j.amjsurg.2008.07.051] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 2.8] [Reference Citation Analysis]
24 Park UJ, Kim YH, Kang KJ, Lim TJ. [Risk factors for early recurrence after surgical resection for hepatocellular carcinoma]. Korean J Hepatol. 2008;14:371-380. [PMID: 18815460 DOI: 10.3350/kjhep.2008.14.3.371] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 0.7] [Reference Citation Analysis]
25 Sun HC, Tang ZY, Wang L, Qin LX, Ma ZC, Ye QH, Zhang BH, Qian YB, Wu ZQ, Fan J. Postoperative interferon alpha treatment postponed recurrence and improved overall survival in patients after curative resection of HBV-related hepatocellular carcinoma: a randomized clinical trial. J Cancer Res Clin Oncol. 2006;132:458-465. [PMID: 16557381 DOI: 10.1007/s00432-006-0091-y] [Cited by in Crossref: 156] [Cited by in F6Publishing: 149] [Article Influence: 9.8] [Reference Citation Analysis]
26 Hao S, Chen S, Yang X, Wan C. Adverse impact of intermittent portal clamping on long-term postoperative outcomes in hepatocellular carcinoma. Ann R Coll Surg Engl 2017;99:22-7. [PMID: 27269234 DOI: 10.1308/rcsann.2016.0183] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
27 Gao J, Duan Z, Zhang L, Huang X, Long L, Tu J, Liang H, Zhang Y, Shen T, Lu F. Failure recovery of circulating NKG2D+CD56dimNK cells in HBV-associated hepatocellular carcinoma after hepatectomy predicts early recurrence. Oncoimmunology 2016;5:e1048061. [PMID: 26942056 DOI: 10.1080/2162402X.2015.1048061] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
28 Kim JH, Sohn BH, Lee HS, Kim SB, Yoo JE, Park YY, Jeong W, Lee SS, Park ES, Kaseb A. Genomic predictors for recurrence patterns of hepatocellular carcinoma: model derivation and validation. PLoS Med. 2014;11:e1001770. [PMID: 25536056 DOI: 10.1371/journal.pmed.1001770] [Cited by in Crossref: 58] [Cited by in F6Publishing: 61] [Article Influence: 7.3] [Reference Citation Analysis]
29 Shankar S, Kalra N, Bhatia A, Srinivasan R, Singh P, Dhiman RK, Khandelwal N, Chawla Y. Role of Diffusion Weighted Imaging (DWI) for Hepatocellular Carcinoma (HCC) Detection and its Grading on 3T MRI: A Prospective Study. J Clin Exp Hepatol. 2016;6:303-310. [PMID: 28003720 DOI: 10.1016/j.jceh.2016.08.012] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 4.0] [Reference Citation Analysis]
30 Hayashi M, Shimizu T, Hirokawa F, Inoue Y, Komeda K, Asakuma M, Miyamoto Y, Takeshita A, Shibayama Y, Tanigawa N. Clinicopathological Risk Factors for Recurrence within One Year after Initial Hepatectomy for Hepatocellular Carcinoma. The American Surgeon 2011;77:572-8. [DOI: 10.1177/000313481107700516] [Cited by in Crossref: 20] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
31 Chou C, Chen Y, Hsu M, Tsai W, Chang C, Chiu C. EFFECT OF SILYMARIN ON LIPID AND ALCOHOL METABOLISM IN MICE FOLLOWING LONG-TERM ALCOHOL CONSUMPTION: HEPATOPROTECTION OF SILYMARIN AGAINST ALCOHOL. Journal of Food Biochemistry 2012;36:369-77. [DOI: 10.1111/j.1745-4514.2011.00543.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
32 An C, Kim DW, Park YN, Chung YE, Rhee H, Kim MJ. Single Hepatocellular Carcinoma: Preoperative MR Imaging to Predict Early Recurrence after Curative Resection. Radiology. 2015;276:433-443. [PMID: 25751229 DOI: 10.1148/radiol.15142394] [Cited by in Crossref: 69] [Cited by in F6Publishing: 68] [Article Influence: 9.9] [Reference Citation Analysis]
33 Allard M, Adam R, Bucur P, Termos S, Cunha AS, Bismuth H, Castaing D, Vibert E. Posthepatectomy Portal Vein Pressure Predicts Liver Failure and Mortality after Major Liver Resection on Noncirrhotic Liver. Annals of Surgery 2013;258:822-30. [DOI: 10.1097/sla.0b013e3182a64b38] [Cited by in Crossref: 85] [Cited by in F6Publishing: 21] [Article Influence: 9.4] [Reference Citation Analysis]
34 Belghiti J, Kianmanesh R. Surgical treatment of hepatocellular carcinoma. HPB (Oxford). 2005;7:42-49. [PMID: 18333160 DOI: 10.1080/13651820410024067] [Cited by in Crossref: 81] [Cited by in F6Publishing: 74] [Article Influence: 6.8] [Reference Citation Analysis]
35 Kim JM, Kwon CH, Joh JW, Park JB, Ko JS, Lee JH, Kim SJ, Park CK. The effect of alkaline phosphatase and intrahepatic metastases in large hepatocellular carcinoma. World J Surg Oncol. 2013;11:40. [PMID: 23432910 DOI: 10.1186/1477-7819-11-40] [Cited by in Crossref: 31] [Cited by in F6Publishing: 34] [Article Influence: 3.4] [Reference Citation Analysis]
36 Wang J, Xu LB, Liu C, Pang HW, Chen YJ, Ou QJ. Prognostic factors and outcome of 438 Chinese patients with hepatocellular carcinoma underwent partial hepatectomy in a single center. World J Surg 2010;34:2434-41. [PMID: 20523993 DOI: 10.1007/s00268-010-0664-4] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
37 Hao S, Chen S, Yang X, Wan C. Impact of intermittent portal clamping on the early recurrence of hepatocellular carcinoma after surgery. Surg Today 2016;46:1290-5. [DOI: 10.1007/s00595-016-1316-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
38 Evdokimova VN, Butterfield LH. Alpha-fetoprotein and other tumour-associated antigens for immunotherapy of hepatocellular cancer. Expert Opin Biol Ther 2008;8:325-36. [PMID: 18294103 DOI: 10.1517/14712598.8.3.325] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
39 Deshpande R, O'Reilly D, Sherlock D. Improving Outcomes with Surgical Resection and Other Ablative Therapies in HCC. Int J Hepatol 2011;2011:686074. [PMID: 21994867 DOI: 10.4061/2011/686074] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
40 Choi KK, Kim SH, Choi SB, Lim JH, Choi GH, Choi JS, Kim KS. Portal venous invasion: the single most independent risk factor for immediate postoperative recurrence of hepatocellular carcinoma. J Gastroenterol Hepatol. 2011;26:1646-1651. [PMID: 21592228 DOI: 10.1111/j.1440-1746.2011.06780.x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 2.8] [Reference Citation Analysis]
41 Lin CJ, Chiu CC, Chen YC, Chen ML, Hsu TC, Tzang BS. Taurine Attenuates Hepatic Inflammation in Chronic Alcohol-Fed Rats Through Inhibition of TLR4/MyD88 Signaling. J Med Food 2015;18:1291-8. [PMID: 26090712 DOI: 10.1089/jmf.2014.3408] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 3.6] [Reference Citation Analysis]
42 Kim SH, Lim HK, Lee WJ, Choi D, Park CK. Scirrhous hepatocellular carcinoma: comparison with usual hepatocellular carcinoma based on CT-pathologic features and long-term results after curative resection. Eur J Radiol. 2009;69:123-130. [PMID: 17976942 DOI: 10.1016/j.ejrad.2007.09.008] [Cited by in Crossref: 49] [Cited by in F6Publishing: 40] [Article Influence: 3.3] [Reference Citation Analysis]
43 Kamiyama T, Nakanishi K, Yokoo H, Kamachi H, Tahara M, Kakisaka T, Tsuruga Y, Todo S, Taketomi A. Analysis of the risk factors for early death due to disease recurrence or progression within 1 year after hepatectomy in patients with hepatocellular carcinoma. World J Surg Oncol. 2012;10:107. [PMID: 22697061 DOI: 10.1186/1477-7819-10-107] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 3.8] [Reference Citation Analysis]
44 Laurent C, Blanc JF, Nobili S, Sa Cunha A, le Bail B, Bioulac-Sage P, Balabaud C, Capdepont M, Saric J. Prognostic factors and longterm survival after hepatic resection for hepatocellular carcinoma originating from noncirrhotic liver. J Am Coll Surg. 2005;201:656-662. [PMID: 16256906 DOI: 10.1016/j.jamcollsurg.2005.05.027] [Cited by in Crossref: 73] [Cited by in F6Publishing: 69] [Article Influence: 4.3] [Reference Citation Analysis]
45 Aktas S, Karakayali H, Moray G, Ozdemir H, Haberal M. Effects of Risk Factors and Ki-67 on Rates of Recurrence on Patients Who Have Undergone Liver Transplant for Hepatocellular Carcinoma. Transplantation Proceedings 2011;43:3807-12. [DOI: 10.1016/j.transproceed.2011.09.067] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
46 Silva A, Greensmith M, Praseedom R, Jah A, Huguet E, Harper S, Liau S, Basu B, Alexander G, Brais R, See T, Hoare M, Gibbs P, Balakrishnan A. Early derangement of INR predicts liver failure after liver resection for hepatocellular carcinoma. The Surgeon 2022. [DOI: 10.1016/j.surge.2022.01.002] [Reference Citation Analysis]
47 Kondo K, Chijiiwa K, Makino I, Kai M, Maehara N, Ohuchida J, Naganuma S. Risk factors for early death after liver resection in patients with solitary hepatocellular carcinoma. J Hepatobiliary Pancreat Surg. 2005;12:399-404. [PMID: 16258809 DOI: 10.1007/s00534-005-1009-9] [Cited by in Crossref: 40] [Cited by in F6Publishing: 42] [Article Influence: 2.5] [Reference Citation Analysis]
48 Chen XX, Cheng JW, Huang A, Zhang X, Wang J, Fan J, Zhou J, Yang XR. The effect of antiviral therapy on patients with hepatitis B virus-related hepatocellular carcinoma after curative resection: a systematic review and meta-analysis. Onco Targets Ther 2017;10:5363-75. [PMID: 29180870 DOI: 10.2147/OTT.S150281] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
49 Morris-stiff G, Gomez D, de Liguori Carino N, Prasad K. Surgical management of hepatocellular carcinoma: Is the jury still out? Surgical Oncology 2009;18:298-321. [DOI: 10.1016/j.suronc.2008.08.003] [Cited by in Crossref: 39] [Cited by in F6Publishing: 38] [Article Influence: 3.0] [Reference Citation Analysis]
50 Cheng Z, Yang P, Qu S, Zhou J, Yang J, Yang X, Xia Y, Li J, Wang K, Yan Z. Risk factors and management for early and late intrahepatic recurrence of solitary hepatocellular carcinoma after curative resection. HPB (Oxford). 2015;17:422-427. [PMID: 25421805 DOI: 10.1111/hpb.12367] [Cited by in Crossref: 58] [Cited by in F6Publishing: 55] [Article Influence: 7.3] [Reference Citation Analysis]
51 Lang H, Sotiropoulos GC, Brokalaki EI, Schmitz KJ, Bertona C, Meyer G, Frilling A, Paul A, Malagó M, Broelsch CE. Survival and recurrence rates after resection for hepatocellular carcinoma in noncirrhotic livers. J Am Coll Surg. 2007;205:27-36. [PMID: 17617329 DOI: 10.1016/j.jamcollsurg.2007.03.002] [Cited by in Crossref: 86] [Cited by in F6Publishing: 78] [Article Influence: 5.7] [Reference Citation Analysis]
52 Hao S, Fan P, Chen S, Tu C, Wan C. Distinct Recurrence Risk Factors for Intrahepatic Metastasis and Multicenter Occurrence After Surgery in Patients with Hepatocellular Carcinoma. J Gastrointest Surg. 2017;21:312-320. [PMID: 27815759 DOI: 10.1007/s11605-016-3311-z] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 4.0] [Reference Citation Analysis]
53 Cui J, Dong BW, Liang P, Yu XL, Yu DJ. Construction and clinical significance of a predictive system for prognosis of hepatocellular carcinoma. World J Gastroenterol 2005; 11(20): 3027-3033 [PMID: 15918184 DOI: 10.3748/wjg.v11.i20.3027] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
54 Benzoni E, Lorenzin D, Favero A, Adani G, Baccarani U, Molaro R, Zompicchiatti A, Saccomano E, Avellini C, Bresadola F, Uzzau A. Liver Resection for Hepatocellular Carcinoma: a Multivariate Analysis of Factors Associated with Improved Prognosis. the Role of Clinical, Pathological and Surgical Related Factors. Tumori 2007;93:264-8. [DOI: 10.1177/030089160709300306] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
55 Ma KW, Cheung TT. When to consider liver transplantation in hepatocellular carcinoma patients? Hepat Oncol. 2017;4:15-24. [PMID: 30191050 DOI: 10.2217/hep-2016-0010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
56 Yang M, Guo Z, Li BG. Risk factors for early recurrence after cryoablation for hepatocellular carcinoma. Shijie Huaren Xiaohua Zazhi 2011; 19(9): 960-963 [DOI: 10.11569/wcjd.v19.i9.960] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
57 Chen QF, Huang T, Si-Tu QJ, Wu P, Shen L, Li W, Huang Z. Analysis of competing endogenous RNA network identifies a poorly differentiated cancer-specific RNA signature for hepatocellular carcinoma. J Cell Biochem 2020;121:2303-17. [PMID: 31642123 DOI: 10.1002/jcb.29454] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
58 Shah SA, Cleary SP, Wei AC, Yang I, Taylor BR, Hemming AW, Langer B, Grant DR, Greig PD, Gallinger S. Recurrence after liver resection for hepatocellular carcinoma: risk factors, treatment, and outcomes. Surgery. 2007;141:330-339. [PMID: 17349844 DOI: 10.1016/j.surg.2006.06.028] [Cited by in Crossref: 258] [Cited by in F6Publishing: 253] [Article Influence: 16.1] [Reference Citation Analysis]
59 Liu HY, Qian HH, Zhang XF, Li J, Yang X, Sun B, Ma JY, Chen L, Yin ZF. Improved method increases sensitivity for circulating hepatocellular carcinoma cells. World J Gastroenterol 2015; 21(10): 2918-2925 [PMID: 25780289 DOI: 10.3748/wjg.v21.i10.2918] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 20] [Article Influence: 3.1] [Reference Citation Analysis]
60 Chau GY. Resection of hepatitis B virus-related hepatocellular carcinoma: Evolving strategies and emerging therapies to improve outcome. World J Gastroenterol 2014; 20(35): 12473-12484 [PMID: 25253947 DOI: 10.3748/wjg.v20.i35.12473] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
61 Unitt E, Marshall A, Gelson W, Rushbrook SM, Davies S, Vowler SL, Morris LS, Coleman N, Alexander GJ. Tumour lymphocytic infiltrate and recurrence of hepatocellular carcinoma following liver transplantation. J Hepatol. 2006;45:246-253. [PMID: 16580084 DOI: 10.1016/j.jhep.2005.12.027] [Cited by in Crossref: 161] [Cited by in F6Publishing: 151] [Article Influence: 10.1] [Reference Citation Analysis]
62 Cucchetti A, Piscaglia F, Grigioni AD, Ravaioli M, Cescon M, Zanello M, Grazi GL, Golfieri R, Grigioni WF, Pinna AD. Preoperative prediction of hepatocellular carcinoma tumour grade and micro-vascular invasion by means of artificial neural network: a pilot study. J Hepatol. 2010;52:880-888. [PMID: 20409605 DOI: 10.1016/j.jhep.2009.12.037] [Cited by in Crossref: 110] [Cited by in F6Publishing: 113] [Article Influence: 9.2] [Reference Citation Analysis]
63 Shao P, Sun D, Wang L, Fan R, Gao Z. Deep sequencing and comprehensive expression analysis identifies several molecules potentially related to human poorly differentiated hepatocellular carcinoma. FEBS Open Bio 2017;7:1696-706. [PMID: 29123978 DOI: 10.1002/2211-5463.12310] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.2] [Reference Citation Analysis]
64 Kobayashi T, Aikata H, Kobayashi T, Ohdan H, Arihiro K, Chayama K. Patients with early recurrence of hepatocellular carcinoma have poor prognosis. Hepatobiliary & Pancreatic Diseases International 2017;16:279-88. [DOI: 10.1016/s1499-3872(16)60181-9] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
65 Tsujita E, Taketomi A, Gion T, Kuroda Y, Endo K, Watanabe A, Nakashima H, Aishima S, Kohnoe S, Maehara Y. Suppressed MKP-1 is an independent predictor of outcome in patients with hepatocellular carcinoma. Oncology. 2005;69:342-347. [PMID: 16293973 DOI: 10.1159/000089766] [Cited by in Crossref: 39] [Cited by in F6Publishing: 32] [Article Influence: 2.3] [Reference Citation Analysis]
66 Xiao CZ, Wei W, Guo ZX, Li SH, Zhang YF, Wang JH, Shi M, Guo RP. A prognosis model for patients with hepatocellular carcinoma and portal vein tumor thrombus following hepatic resection. Oncol Lett. 2015;10:2787-2794. [PMID: 26722243 DOI: 10.3892/ol.2015.3677] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
67 Nakanishi M, Chuma M, Hige S, Omatsu T, Yokoo H, Nakanishi K, Kamiyama T, Kubota K, Haga H, Matsuno Y. Relationship between diffusion-weighted magnetic resonance imaging and histological tumor grading of hepatocellular carcinoma. Ann Surg Oncol. 2012;19:1302-1309. [PMID: 21927976 DOI: 10.1245/s10434-011-2066-8] [Cited by in Crossref: 85] [Cited by in F6Publishing: 92] [Article Influence: 7.7] [Reference Citation Analysis]
68 Morris-stiff G, Marangoni G, Hakeem A, Farida SG, Gomez D, Toogood GJ, Lodge JPA, Raj Prasad K. Redefining major hepatic resection for colorectal liver metastases: Analysis of 1111 liver resections. International Journal of Surgery 2016;25:172-7. [DOI: 10.1016/j.ijsu.2015.07.711] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
69 Iavarone M, Sangiovanni A, Forzenigo LV, Massironi S, Fraquelli M, Aghemo A, Ronchi G, Biondetti P, Roncalli M, Colombo M. Diagnosis of hepatocellular carcinoma in cirrhosis by dynamic contrast imaging: the importance of tumor cell differentiation. Hepatology. 2010;52:1723-1730. [PMID: 20842697 DOI: 10.1002/hep.23903] [Cited by in Crossref: 47] [Cited by in F6Publishing: 37] [Article Influence: 3.9] [Reference Citation Analysis]
70 Chuang YH, Ou HY, Yu CY, Chen CL, Weng CC, Tsang LL, Hsu HW, Lim WX, Huang TL, Cheng YF. Diffusion-weighted imaging for identifying patients at high risk of tumor recurrence following liver transplantation. Cancer Imaging 2019;19:74. [PMID: 31730015 DOI: 10.1186/s40644-019-0264-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
71 Takagi K, Takayama T, Nagase H, Moriguchi M, Wang X, Hirayanagi K, Suzuki T, Hasegawa H, Ochiai T, Yamaguchi N, Kochi M, Kimura M, Esumi M. High TSC22D3 and low GBP1 expression in the liver is a risk factor for early recurrence of hepatocellular carcinoma. Exp Ther Med 2011;2:425-31. [PMID: 22977521 DOI: 10.3892/etm.2011.236] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
72 Tao KS, Dou KF, Wu XA. Expression of angiostatin cDNA in human hepatocellular carcinoma cell line SMMC-7721 and its effect on implanted carcinoma in nude mice. World J Gastroenterol 2004; 10(10): 1421-1424 [PMID: 15133846 DOI: 10.3748/wjg.v10.i10.1421] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
73 Kim BW, Kim YB, Wang HJ, Kim MW. Risk factors for immediate post-operative fatal recurrence after curative resection of hepatocellular carcinoma. World J Gastroenterol 2006; 12(1): 99-104 [PMID: 16440425 DOI: 10.3748/wjg.v12.i1.99] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 23] [Article Influence: 1.4] [Reference Citation Analysis]
74 Ramzan M, Sturm N, Decaens T, Bioulac-Sage P, Bancel B, Merle P, Tran Van Nhieu J, Slama R, Letoublon C, Zarski JP. Liver-infiltrating CD8(+) lymphocytes as prognostic factor for tumour recurrence in hepatitis C virus-related hepatocellular carcinoma. Liver Int. 2016;36:434-444. [PMID: 26215124 DOI: 10.1111/liv.12927] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 3.0] [Reference Citation Analysis]
75 Zhong NB, Lv GM, Chen ZH. Stereotactic body radiotherapy combined with transarterial chemoembolization for huge (≥10 cm) hepatocellular carcinomas: A clinical study. Mol Clin Oncol 2014;2:839-44. [PMID: 25054055 DOI: 10.3892/mco.2014.304] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 2.8] [Reference Citation Analysis]
76 Rungsakulkij N, Mingphruedhi S, Suragul W, Tangtawee P, Muangkaew P, Aeesoa S. Platelet-to-Lymphocyte Ratio and Large Tumor Size Predict Microvascular Invasion after Resection for Hepatocellular Carcinoma. Asian Pac J Cancer Prev 2018;19:3435-41. [PMID: 30583666 DOI: 10.31557/APJCP.2018.19.12.3435] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
77 Wang XM, Yin ZY, Yu RX, Peng YY, Liu PG, Wu GY. Preventive effect of regional radiotherapy with phosphorus-32 glass microspheres in hepatocellular carcinoma recurrence after hepatectomy. World J Gastroenterol 2008; 14(4): 518-523 [PMID: 18203282 DOI: 10.3748/wjg.14.518] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
78 Zhao Y, Wu J, Zhang Q, Hua Z, Qi W, Wang N, Lin T, Sheng L, Cui D, Liu J, Song Q, Li X, Wu T, Guo Y, Cui J, Liu A. Radiomics Analysis Based on Multiparametric MRI for Predicting Early Recurrence in Hepatocellular Carcinoma After Partial Hepatectomy. J Magn Reson Imaging. 2020;. [PMID: 33217114 DOI: 10.1002/jmri.27424] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
79 Khandoga A, Drefs M, Schoenberg M, Schiergens T, Frenes K, Op den Winkel M, Trumm C, Angele MK, Guba M, Werner J, Rentsch M. Differential significance of early surgical complications for acute and long-term recurrence-free survival following surgical resection of hepatocellular carcinoma: do comorbidities play a role? Eur J Gastroenterol Hepatol 2017;29:1045-53. [PMID: 28562395 DOI: 10.1097/MEG.0000000000000912] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 2.3] [Reference Citation Analysis]
80 Vauthey JN, Pawlik TM, Ribero D, Wu TT, Zorzi D, Hoff PM, Xiong HQ, Eng C, Lauwers GY, Mino-Kenudson M, Risio M, Muratore A, Capussotti L, Curley SA, Abdalla EK. Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol 2006;24:2065-72. [PMID: 16648507 DOI: 10.1200/JCO.2005.05.3074] [Cited by in Crossref: 932] [Cited by in F6Publishing: 327] [Article Influence: 58.3] [Reference Citation Analysis]
81 Lai MW, Huang SF, Lin SM, Chen TC, Lin CY, Yeh CN, Yeh TS, Chen MF, Yeh CT. Expression of the HCRP1 mRNA in HCC as an independent predictor of disease-free survival after surgical resection. Hepatol Res 2009;39:164-76. [PMID: 19208037 DOI: 10.1111/j.1872-034X.2008.00413.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
82 Chen IS, Chen YC, Chou CH, Chuang RF, Sheen LY, Chiu CH. Hepatoprotection of silymarin against thioacetamide-induced chronic liver fibrosis. J Sci Food Agric. 2012;92:1441-1447. [PMID: 22102319 DOI: 10.1002/jsfa.4723] [Cited by in Crossref: 64] [Cited by in F6Publishing: 58] [Article Influence: 5.8] [Reference Citation Analysis]
83 Ning P, Gao F, Hai J, Wu M, Chen J, Zhu S, Wang M, Shi D. Application of CT radiomics in prediction of early recurrence in hepatocellular carcinoma. Abdom Radiol (NY). 2020;45:64-72. [PMID: 31486869 DOI: 10.1007/s00261-019-02198-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
84 Shah SA, Wei AC, Cleary SP, Yang I, McGilvray ID, Gallinger S, Grant DR, Greig PD. Prognosis and results after resection of very large (>or=10 cm) hepatocellular carcinoma. J Gastrointest Surg. 2007;11:589-595. [PMID: 17393258 DOI: 10.1007/s11605-007-0154-7] [Cited by in Crossref: 68] [Cited by in F6Publishing: 61] [Article Influence: 4.5] [Reference Citation Analysis]
85 Egger ME, Ohlendorf JM, Scoggins CR, McMasters KM, Martin RC 2nd. Assessment of the reporting of quality and outcome measures in hepatic resections: a call for 90-day reporting in all hepatectomy series. HPB (Oxford) 2015;17:839-45. [PMID: 26228262 DOI: 10.1111/hpb.12470] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.6] [Reference Citation Analysis]
86 Lee HY, Rhim H, Lee MW, Kim YS, Choi D, Park MJ, Kim YK, Kim SH, Lim HK. Early diffuse recurrence of hepatocellular carcinoma after percutaneous radiofrequency ablation: analysis of risk factors. Eur Radiol. 2013;23:190-197. [PMID: 23085860 DOI: 10.1007/s00330-012-2561-8] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 3.2] [Reference Citation Analysis]
87 Rong D, Liu W, Kuang S, Xie S, Chen Z, Chen F, Xie Q, Luo Q, He B, Zhang Y, Deng Y, Yang H, Chen S, Wang J. Preoperative prediction of pathologic grade of HCC on gadobenate dimeglumine-enhanced dynamic MRI. Eur Radiol 2021. [PMID: 33860826 DOI: 10.1007/s00330-021-07891-0] [Reference Citation Analysis]
88 Liu H, Liu Y, Yu T, Ye N, Wang Q. Evaluation of apparent diffusion coefficient associated with pathological grade of lung carcinoma, before therapy. J Magn Reson Imaging 2015;42:595-601. [PMID: 25537656 DOI: 10.1002/jmri.24823] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
89 Shah SA, Greig PD, Gallinger S, Cattral MS, Dixon E, Kim RD, Taylor BR, Grant DR, Vollmer CM. Factors associated with early recurrence after resection for hepatocellular carcinoma and outcomes. J Am Coll Surg. 2006;202:275-283. [PMID: 16427553 DOI: 10.1016/j.jamcollsurg.2005.10.005] [Cited by in Crossref: 160] [Cited by in F6Publishing: 161] [Article Influence: 9.4] [Reference Citation Analysis]
90 Kamiyama T, Takahashi M, Nakanishi K, Yokoo H, Kamachi H, Kobayashi N, Ozaki M, Todo S. α-fetoprotein, vascular endothelial growth factor receptor-1 and early recurrence of hepatoma. World J Gastroenterol 2012; 18(4): 340-348 [PMID: 22294840 DOI: 10.3748/wjg.v18.i4.340] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
91 Pawlik TM, Delman KA, Vauthey JN, Nagorney DM, Ng IO, Ikai I, Yamaoka Y, Belghiti J, Lauwers GY, Poon RT, Abdalla EK. Tumor size predicts vascular invasion and histologic grade: Implications for selection of surgical treatment for hepatocellular carcinoma. Liver Transpl. 2005;11:1086-1092. [PMID: 16123959 DOI: 10.1002/lt.20472] [Cited by in Crossref: 401] [Cited by in F6Publishing: 385] [Article Influence: 23.6] [Reference Citation Analysis]
92 Fartoux L, Decaens T. Contribution of biomarkers and imaging in the management of hepatocellular carcinoma. Clin Res Hepatol Gastroenterol. 2011;35 Suppl 1:S21-S30. [PMID: 21742297 DOI: 10.1016/s2210-7401(11)70004-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
93 Bang H, Ha SY, Hwang SH, Park CK. Expression of PEG10 Is Associated with Poor Survival and Tumor Recurrence in Hepatocellular Carcinoma. Cancer Res Treat 2015;47:844-52. [PMID: 25687862 DOI: 10.4143/crt.2014.124] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 3.4] [Reference Citation Analysis]
94 Jiang T, Xu JH, Zou Y, Chen R, Peng LR, Zhou ZD, Yang M. Diffusion-weighted imaging (DWI) of hepatocellular carcinomas: a retrospective analysis of the correlation between qualitative and quantitative DWI and tumour grade. Clin Radiol. 2017;72:465-472. [PMID: 28109531 DOI: 10.1016/j.crad.2016.12.017] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
95 Milliken D, Curtis S, Melikian C. Predicting morbidity in liver resection surgery: external validation of the revised frailty index and development of a novel predictive model. HPB (Oxford) 2021;23:954-61. [PMID: 33168438 DOI: 10.1016/j.hpb.2020.10.012] [Reference Citation Analysis]
96 Chou C, Chang Y, Tzang B, Hsu C, Lin Y, Lin H, Chen Y. Effects of taurine on hepatic lipid metabolism and anti-inflammation in chronic alcohol-fed rats. Food Chemistry 2012;135:24-30. [DOI: 10.1016/j.foodchem.2012.04.036] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]